MSD reports Phase III SMART trial outcomes for infants’ RSV risk
The results indicate that safety in children under two years was consistent across both RSV seasons receiving Enflonsia.
Clinical Trials
Serina Therapeutics enrols first patient for SER-252 trial
Lilly reports positive top line data for TOGETHER-PsO Phase IIIb trial
Novartis’ RemIND trial of oral remibrutinib meets primary endpoint
Cyrano reports positive data from Phase II trial of CYR-064
Janux commences participant dosing in Phase I JANX011 trial
First patient recruited in North Midlands CRDC’s stroke trial
CStone secures FDA clearance to begin CS2009 Phase II trial
